Electra Therapeutics Inc. (ETRA) vs REGENXBIO Inc. (RGNX)

Electra Therapeutics Inc. ETRA 7.87 −2.48%
REGENXBIO Inc. RGNX 7.64 +0.13%

Electra Therapeutics Inc. and REGENXBIO Inc. are both Biotechnology companies. Electra Therapeutics Inc. and REGENXBIO Inc. are of similar size ($506.5M and $503.7M).

Metric	ETRA	RGNX	Biotechnology median
P/E	—	n/m	10.64
P/S	—	2.30	9.59
P/B	—	5.59	2.15
Price to free cash flow	—	n/m	26.07
EV/EBITDA	—	n/m	0.65
EV/Sales	—	1.73	9.45
Earnings yield	—	(49.87%)	(34.69%)
Free cash flow yield	—	(62.19%)	(24.02%)

Metric	ETRA	RGNX	Biotechnology median
Gross margin	—	86.38%	65.59%
Operating margin	—	(94.08%)	0.00%
Net margin	—	(112.58%)	0.00%
Free cash flow margin	—	(143.09%)	0.00%
Return on equity	—	(137.63%)	(51.96%)
Return on assets	—	(40.60%)	(46.06%)
Return on invested capital	—	0.00%	0.00%

Metric	ETRA	RGNX	Biotechnology median
Revenue growth (TTM)	—	12.00%	4.59%
EPS growth (last fiscal year)	—	18.08%	29.88%
Revenue growth, 5-year CAGR	—	1.97%	9.75%
Net income growth, 5-year CAGR	—	0.00%	0.00%

Metric	ETRA	RGNX	Biotechnology median
Debt to equity	—	0.00	0.00
Current ratio	—	2.86	4.86
Net debt to EBITDA	—	1.58	1.01

Metric	ETRA	RGNX	Biotechnology median
Dividend yield	—	—	0.38%
Payout ratio	—	—	—

Metric	ETRA	RGNX	Biotechnology median
Market cap	506.53m	503.68m	174.29m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack